Engineering Nanoparticles to Tackle Tumor Barriers.

Jiaxian Li,Qingqing Huang,Jingyang Zhang,Jin‐Zhi Du

DOI: https://doi.org/10.1039/d0tb00967a

IF: 7.571

2020-01-01

Journal of Materials Chemistry B

Abstract:Engineering strategies of nanoparticles were elaborated to overcome delivery barriers from the perspectives of trans-vascular transport and interstitial transport.

What problem does this paper attempt to address?

Engineering nanoparticles to tackle tumor barriers

Jia-Xian Li,Qiu-Yue Huang,Jing-Yang Zhang,Jin-Zhi Du

DOI: https://doi.org/10.1039/d0tb00967a

IF: 7.571

2020-01-01

Journal of Materials Chemistry B

Abstract:Engineering nanoparticles (NPs) as delivery systems of anticancer therapeutics has attracted tremendous attention in recent decades, and some nanoscale drug formulations have been approved for clinical use. However, their therapeutic efficacies are still limited by the presence of a series of biological barriers during the delivery process. Among these obstacles, tumor barriers are generally recognized as the bottleneck, because they dominate the NP extravasation from the tumor vasculature and penetration into the tumor parenchyma. Therefore, this review first discussed tumor barriers from two aspects: tumor vascular barriers and tumor stromal barriers. Pathological features of the two sets of barriers as well as their influence on the delivery efficacy were described. Then, we outlined strategies for engineering NPs to overcome these challenges: increasing extravasation through physical property optimization and tumor vascular targeting; and facilitating deep penetration through particle size manipulation, modulation of the tumor extracellular matrix, and some new mechanisms. This review will provide a critical perspective on engineering strategies for more efficient nanomedicine in oncology.
Recent Advances in Nanostrategies Capable of Overcoming Biological Barriers for Tumor Management

Da Huo,Xiqun Jiang,Yong Hu

DOI: https://doi.org/10.1002/adma.201904337

IF: 29.4

2019-01-01

Advanced Materials

Abstract:Engineered nanomaterials have been extensively employed as therapeutics for tumor management. Meanwhile, the complex tumor niche along with multiple barriers at the cellular level collectively hinders the action of nanomedicines. Here, the advanced strategies that hold promise for overcoming the numerous biological barriers facing nanomedicines are summarized. Starting from tumor entry, methods that promote tissue penetration of nanomedicine and address the hypoxia issue are also highlighted. Then, emphasis is given to the significance of overcoming both physical barriers, such as membrane‐associated efflux pumps, and biological features, such as resistance to apoptosis. The pros and cons for an individual approach are presented. In addition, the associated technical problems are discussed, along with the importance of balancing the therapeutic merits and the additional cost of sophisticated nanomedicine designs.
Nano‐Engineering Strategies for Tumor‐Specific Therapy

Zijin Li,Hai-Yan Xie,Weidong Nie

DOI: https://doi.org/10.1002/cmdc.202300647

IF: 3.54

2024-02-16

ChemMedChem

Abstract:Nanodelivery systems (NDSs) provide promising prospects for decreasing drug doses, reducing side effects, and improving therapeutic effects. However, the bioapplications of NDSs are still compromised by their fast clearance, indiscriminate biodistribution, and limited tumor accumulation. Hence, engineering modification of NDSs aiming at promoting tumor‐specific therapy and avoiding systemic toxicity is usually needed. An NDS integrating various functionalities, including flexible camouflage, specific biorecognition, and sensitive stimuli‐responsiveness, into one sequence would be "smart" and highly effective. Herein, we systematically summarize the related principles, methods, and progress. At the end of the review, we predict the obstacles to precise nanoengineering and prospects for the future application of NDSs.

pharmacology & pharmacy,chemistry, medicinal
Nano-engineering nanomedicines with customized functions for tumor treatment applications

Yuxin Wang,Shimei Li,Xiangling Ren,Shiping Yu,Xianwei Meng

DOI: https://doi.org/10.1186/s12951-023-01975-3

IF: 10.2

2023-08-04

Journal of Nanobiotechnology

Abstract:Nano-engineering with unique "custom function" capability has shown great potential in solving technical difficulties of nanomaterials in tumor treatment. Through tuning the size and surface properties controllablly, nanoparticles can be endoewd with tailored structure, and then the characteristic functions to improve the therapeutic effect of nanomedicines. Based on nano-engineering, many have been carried out to advance nano-engineering nanomedicine. In this review, the main research related to cancer therapy attached to the development of nanoengineering nanomedicines has been presented as follows. Firstly, therapeutic agents that target to tumor area can exert the therapeutic effect effectively. Secondly, drug resistance of tumor cells can be overcome to enhance the efficacy. Thirdly, remodeling the immunosuppressive microenvironment makes the therapeutic agents work with the autoimmune system to eliminate the primary tumor and then prevent tumor recurrence and metastasis. Finally, the development prospects of nano-engineering nanomedicine are also outlined.

biotechnology & applied microbiology,nanoscience & nanotechnology
New Nanomaterials and Techniques for Tumor-targeted Systems

r huang,y wang

DOI: https://doi.org/10.1007/978-981-15-5159-8

2020-01-01

Abstract:The ultimate goal of cancer nanomedicine is to specifically increase the drug accumulation in tumor and reduce side effects. Although nanomedicine has made great progress in recent decades, its delivery efficacy is still suboptimal, which hinders its clinical translation. Currently, most drug delivery vehicles are delivered by systemic administration, and physiological barriers prevent effective accumulation of nanomedicine at the tumor site. These nanocarriers must reach the tumor tissue after the long journey in blood circulation, then access to tumor cells deep inside the tumor by overcoming the tumor tissue barrier, and finally kill the tumor cells after entering the cell. Successful design of nanocarriers must fully consider the existing delivery barriers in order to achieve better therapeutic efficacy. This chapter summarizes obstacles experienced by nanomedicine from the site of injection and the site of action as well as exemplifies typical strategies for overcoming these barriers, hopefully providing insights into the design of more effective nanomedicine.
Strategies to improve tumor penetration of nanomedicines through nanoparticle design

Ya-Ru Zhang,Run Lin,Hong-Jun Li,Wei-ling He,Jin-Zhi Du,Jun Wang

DOI: https://doi.org/10.1002/wnan.1519

2019-01-01

Abstract:Nanoparticles (NPs) have emerged as an effective means to deliver therapeutic drugs for cancer treatment, as they can preferentially accumulate at tumor site through the enhanced permeability and retention effect. Various forms of NPs including liposomes, polymeric micelles, and inorganic particles have been used for therapeutic applications. However, the therapeutic benefits of nanomedicines are suboptimal. Although many possible reasons may account for the compromised therapeutic efficacy, the inefficient tumor penetration can be a vital obstacle. Tumor develops characteristic pathological environment, such as abnormal vasculature, elevated interstitial fluid pressure, and dense extracellular matrix, which intrinsically hinder the transport of nanomedicines in the tumor parenchyma. The physicochemical properties of the NPs such as size, shape, and surface charge have profound effect on tumor penetration. In this review, we will highlight the factors that affect the transport of NPs in solid tumor, and then elaborate on designing strategies to improve NPs' penetration and uniform distribution inside the tumor interstitium. This article is categorized under: Therapeutic Approaches and Drug Discovery > Nanomedicine for Oncologic Disease
Recent Advances in Drug Delivery Systems for Enhancing Drug Penetration into Tumors

Bin He,Xin Sui,Bing Yu,Song Wang,Youqing Shen,Hailin Cong

DOI: https://doi.org/10.1080/10717544.2020.1831106

IF: 6.819

2020-01-01

Drug Delivery

Abstract:The emergence of nanomaterials for drug delivery provides the opportunity to avoid the side effects of systemic drug administration and injury caused by the removal of tumors, delivering great promise for future cancer treatments. However, the efficacy of current nano drugs is not significantly better than that of the original drug treatments. The important reason is that nano drugs enter the tumor vasculature, remaining close to the blood vessels and unable to enter the tumor tissue or tumor cells to complete the drug delivery process. The low efficiency of drug penetration into tumors has become a bottleneck restricting the development of nano-drugs. Herein, we present a systematic overview of recent advances on the design of nano-drug carriers in drug delivery systems for enhancing drug penetration into tumors. The review is organized into four sections: The drug penetration process in tumor tissue includes paracellular and transcellular transport, which is summarized first. Strategies that promote tumor penetration are then introduced, including methods of remodeling the tumor microenvironment, charge inversion, dimensional change, and surface modification of ligands which promote tissue penetration. Conclusion and the prospects for the future development of drug penetration are finally briefly illustrated. The review is intended to provide thoughts for effective treatment of cancer by summarizing strategies for promoting the endocytosis of nano drugs into tumor cells.
Barrier permeation and improved nanomedicine delivery in tumor microenvironments

Jinxiang Liu,Jiaying Zhang,Yang Gao,Yuxuan Jiang,Zhenxin Guan,Yiying Xie,Jinghui Hu,Jing Chen

DOI: https://doi.org/10.1016/j.canlet.2023.216166

IF: 9.756

2023-04-07

Cancer Letters

Abstract:Nanomedicines can effectively penetrate tumor sites compared to traditionally used drugs. However, effective drugs that reach the interior of tumors remain limited. Based on studies of the complex tumor microenvironment, we summarized the barriers restricting tumor penetration of nanomedicines in this review. Penetration barriers are mainly caused by tumor blood vessels, stroma, and cell abnormalities. The repair of abnormal tumor blood vessels and tumor stroma and adjusting the physicochemical properties of nanoparticles are considered promising strategies to improve the tumor permeation of nanomedicines. The effects of nanoparticle properties, including size, shape, and surface charge, on tumor penetration were also reviewed. We expect to provide research ideas and a scientific basis for nanomedicines to increase intratumoral permeability and improve anti-tumor effects.

oncology
The Design and Application of Nanomaterials as Drug Carriers in Cancer Treatment

Jia Hou,Xiaoyan Sun,Ying Huang,Shaohua Yang,Junjie Liu,Changhao Feng,Jun Ma,Bin Chen

DOI: https://doi.org/10.2174/0929867326666190816231409

IF: 4.74

2020-11-04

Current Medicinal Chemistry

Abstract:The development of new medical cancer treatment technologies is of great significance in reducing cancer mortality. Traditional clinical cancer therapy has a short drug action time, difficulty in accurately targeting tumour tissues and high levels of toxicity in normal tissues. With the development of nanotechnology, nanomaterials have been used as drug carriers to specifically target cancer cells and release drugs into the tumour environment. This technique has become an important research hotspot in cancer treatment. There are several advantages of using nanomaterials for cancer treatment that improve the efficacy of drug delivery, including increased drug concentrations in the targeted tumour area, reduced toxicity in normal tissues and controlled drug release. In this work, we describe the latest research development on the use of nanomaterials for drug delivery in cancer treatment and explore related mechanistic pathways. In addition, the methods used to control drug release into the targeted area using nanocarriers are reviewed in detail. Overall, we present current achievements using nanomaterials and nanotechnologies in cancer treatment, followed by current challenges and future prospects.

pharmacology & pharmacy,biochemistry & molecular biology,chemistry, medicinal
Strategies for Delivering Nanoparticles across Tumor Blood Vessels

Vinit Sheth,Lin Wang,Resham Bhattacharya,Priyabrata Mukherjee,Stefan Wilhelm

DOI: https://doi.org/10.1002/adfm.202007363

IF: 19

2020-11-12

Advanced Functional Materials

Abstract:<p>Nanoparticle transport across tumor blood vessels is a key step in nanoparticle delivery to solid tumors. However, the specific pathways and mechanisms of this nanoparticle delivery process are not fully understood. Here, the biological and physical characteristics of the tumor vasculature and the tumor microenvironment are explored and how these features affect nanoparticle transport across tumor blood vessels is discussed. The biological and physical methods to deliver nanoparticles into tumors are reviewed and paracellular and transcellular nanoparticle transport pathways are explored. Understanding the underlying pathways and mechanisms of nanoparticle tumor delivery will inform the engineering of safer and more effective nanomedicines for clinical translation.</p>

materials science, multidisciplinary,chemistry, physical,physics, applied, condensed matter,nanoscience & nanotechnology
Bioengineering nanomaterials for tumor therapy and anti-metastasis

Junjie Cheng,Yuanbo Pan,Jianhua Zou,Miya Zhang,Yang Zhu,Yangzhong Liu,Xiaoyuan Chen

DOI: https://doi.org/10.1016/j.pmatsci.2024.101375

IF: 48.165

2024-09-21

Progress in Materials Science

Abstract:Tumor metastasis, responsible for the majority of cancer-related mortality, represents a critical challenge to effective treatment. Despite the deployment of various therapeutic strategies, difficulties remain due to tumor heterogeneity and the complexity of the biological microenvironment. Functional nanomaterials possess unique acoustic, optical, electromagnetic, and thermal properties, playing critical tools in the treatment of tumors and holding substantial potential for improving therapeutic outcomes. However, prior to clinical implementation, critical factors such as dispersion, targeting, immunogenicity, in vivo biodistribution, and biosafety must be thoroughly evaluated. In this review, we focus on the recent advancements in the use of bioengineered nanomaterials for treating tumor metastasis. We emphasize the design, composition, and construction methods of these nanomaterials, along with their mechanisms of action and notable breakthroughs in anti-metastasis therapy. Furthermore, we outline early detection techniques for tumor metastasis. By elucidating the significant potential of these nanomaterials, the associated challenges and prospects for clinical translation are discussed as well, with the aim of encouraging high-quality research and promoting the potential clinical applications of bioengineered nanomaterials in the fight against tumor metastasis

materials science, multidisciplinary
"Targeting Design" of Nanoparticles in Tumor Therapy

Tingting Yang,Jingming Zhai,Dong Hu,Ruyue Yang,Guidan Wang,Yuanpei Li,Gaofeng Liang

DOI: https://doi.org/10.3390/pharmaceutics14091919

IF: 6.525

2022-09-12

Pharmaceutics

Abstract:Tumor-targeted therapy based on nanoparticles is a popular research direction in the biomedical field. After decades of research and development, both the passive targeting ability of the inherent properties of NPs and the active targeting based on ligand receptor interaction have gained deeper understanding. Unfortunately, most targeted delivery strategies are still in the preclinical trial stage, so it is necessary to further study the biological fate of particles in vivo and the interaction mechanism with tumors. This article reviews different targeted delivery strategies based on NPs, and focuses on the physical and chemical properties of NPs (size, morphology, surface and intrinsic properties), ligands (binding number/force, activity and species) and receptors (endocytosis, distribution and recycling) and other factors that affect particle targeting. The limitations and solutions of these factors are further discussed, and a variety of new targeting schemes are introduced, hoping to provide guidance for future targeting design and achieve the purpose of rapid transformation of targeted particles into clinical application.

pharmacology & pharmacy
The progress and perspective of strategies to improve tumor penetration of nanomedicines

Jiang Hu,Xinwei Yuan,Fei Wang,Huile Gao,Xilin Liu,Wei Zhang

DOI: https://doi.org/10.1016/j.cclet.2020.11.006

IF: 9.1

2021-04-01

Chinese Chemical Letters

Abstract:<p>Tumor penetration is important for effectively tumor targeting drug delivery. Recently, many researches are published to overcome the barriers that restrict tumor penetration and improve drug delivery efficiency. In the mini review, we first analyzed the barriers influence the tumor penetration, including tumor microenvironment barriers, nanoparticle properties, and interaction barriers between tumor and nanoparticles. To overcome the barrier, several strategies are developed, including modulating tumor microenvironment, changing particle size, transcytosis enabled tumor penetration, cell penetrating peptide modification and overcoming binding site barrier, which could effectively improve tumor penetration, and finally enhance tumor treatment outcome.</p>

chemistry, multidisciplinary
Overcoming tumor microenvironment obstacles: Current approaches for boosting nanodrug delivery

Xiaohui Wang,Hong Zhang,Xiaohui Chen,Chunrong Wu,Ke Ding,Guiyin Sun,Yang Luo,Debing Xiang

DOI: https://doi.org/10.1016/j.actbio.2023.05.043

IF: 10.633

2023-05-31

Acta Biomaterialia

Abstract:In order to achieve targeted delivery of anticancer drugs, efficacy improvement, and side effect reduction, various types of nanoparticles are employed. However, their therapeutic effects are not ideal. This phenomenon is caused by tumor microenvironment abnormalities such as abnormal blood vessels, elevated interstitial fluid pressure, and dense extracellular matrix that affect nanoparticle penetration into the tumor's interstitium. Furthermore, nanoparticle properties including size, charge, and shape affect nanoparticle transport into tumors. This review comprehensively goes over the factors hindering nanoparticle penetration into tumors and describes methods for improving nanoparticle distribution by remodeling the tumor microenvironment and optimizing nanoparticle physicochemical properties. Finally, a critical analysis of future development of nanodrug delivery in oncology is further discussed. Statement of Significance : This article reviews the factors that hinder the distribution of nanoparticles in tumors, and describes existing methods and approaches for improving the tumor accumulation from the aspects of remodeling the tumor microenvironment and optimizing the properties of nanoparticles. The description of the existing methods and approaches is followed by highlighting their advantages and disadvantages and put forward possible directions for the future researches. At last, the challenges of improving tumor accumulation in nanomedicines design were also discussed. This review will be of great interest to the broad readers who are committed to delivering nanomedicine for cancer treatment.

engineering, biomedical,materials science, biomaterials
Engineering nanoparticles to reprogram radiotherapy and immunotherapy: recent advances and future challenges

Jing Jin,Qijie Zhao

DOI: https://doi.org/10.1186/s12951-020-00629-y

IF: 10.2

2020-05-14

Journal of Nanobiotechnology

Abstract:Nanoparticles (NPs) have been increasingly studied for radiosensitization. The principle of NPs radio-enhancement is to use high-atomic number NPs (e.g. gold, hafnium, bismuth and gadolinium) or deliver radiosensitizing substances, such as cisplatin and selenium. Nowadays, cancer immunotherapy is emerged as a promising treatment and immune checkpoint regulation has a potential property to improve clinical outcomes in cancer immunotherapy. Furthermore, NPs have been served as an ideal platform for immunomodulator system delivery. Owing to enhanced permeability and retention (EPR) effect, modified-NPs increase the targeting and retention of antibodies in target cells. The purpose of this review is to highlight the latest progress of nanotechnology in radiotherapy (RT) and immunotherapy, as well as combining these three strategies in cancer treatment. Overall, nanomedicine as an effective strategy for RT can significantly enhance the outcome of immunotherapy response and might be beneficial for clinical transformation.

biotechnology & applied microbiology,nanoscience & nanotechnology
Engineered nanoparticles for precise targeted drug delivery and enhanced therapeutic efficacy in cancer immunotherapy

Xueqiang Peng,Jianjun Fang,Chuyuan Lou,Liang Yang,Shaobo Shan,Zixian Wang,Yutong Chen,Hangyu Li,Xuexin Li

DOI: https://doi.org/10.1016/j.apsb.2024.05.010

IF: 14.903

2024-05-15

Acta Pharmaceutica Sinica B

Abstract:The advent of cancer immunotherapy has imparted a transformative impact on cancer treatment paradigms by harnessing the power of the immune system. However, the challenge of practical and precise targeting of malignant cells persists. To address this, engineered nanoparticles (NPs) have emerged as a promising solution for enhancing targeted drug delivery in immunotherapeutic interventions, owing to their small size, low immunogenicity, and ease of surface modification. This comprehensive review delves into contemporary research at the nexus of NP engineering and immunotherapy, encompassing an extensive spectrum of NP morphologies and strategies tailored toward optimizing tumor targeting and augmenting therapeutic effectiveness. Moreover, it underscores the mechanisms that NPs leverage to bypass the numerous obstacles encountered in immunotherapeutic regimens and probes into the combined potential of NPs when co-administered with both established and novel immunotherapeutic modalities. Finally, the review evaluates the existing limitations of NPs as drug delivery platforms in immunotherapy, which could shape the path for future advancements in this promising field.

pharmacology & pharmacy
Engineering Small Molecule Nanodrugs to Overcome Barriers for Cancer Therapy

Yuan Ma,Quanbing Mou,Deyue Yan,Xinyuan Zhu

DOI: https://doi.org/10.1002/viw.20200062

2020-01-01

View

Abstract:AbstractSmall molecule nanodrugs consisting of pure drugs, drug‐drug dimers, drug‐drug conjugates, or drug derivatives could realize drug delivery by themselves without the aid of carriers, which have received abundant attention in recent decades. Avoiding the use of additional carriers, the yielded small molecule nanodrugs hold the following advantages: (a) high drug loading capacities (some of them could even reach up to 100%); (b) precise and tunable drug loading ration; and (c) no carrier‐induced long‐term toxicity. The past decade has witnessed rapid growth and advancements in this field. In this review, we will briefly introduce both in vitro “barriers” and in vivo barriers for drug delivery, and then summarize the most recent development of small molecule nanodrugs from the point of view how to engineer small molecule nanodrugs to overcome these barriers.
Circumventing Tumor Resistance to Chemotherapy by Nanotechnology

Xing-Jie Liang,Chunying Chen,Yuliang Zhao,Paul C. Wang

DOI: https://doi.org/10.1007/978-1-60761-416-6_21

2009-10-05

Abstract:Patient relapse and metastasis of malignant cells is very common after standard cancer treatment with surgery, radiation, and/or chemotherapy. Chemotherapy, a cornerstone in the development of present day cancer therapy, is one of the most effective and potent strategies to treat malignant tumors. However, the resistance of cancer cells to the drugs remains a significant impediment to successful chemotherapy. An additional obstacle is the inability of chemotherapeutic drugs to selectively target tumor cells. Almost all the anticancer agents have severe side effects on normal tissues and organs. The toxicity of currently available anticancer drugs and the inefficiency of chemotherapeutic treatments, especially for advanced stages of the disease, have limited the optimization of clinical drug combinations and effective chemotherapeutic protocols. Nanomedicine allows the release of drugs by biodegradation and self-regulation of nanomaterials in vitro and in vivo. Nanotechnologies are characterized by effective drug encapsulation, controllable self-assembly, specificity and biocompatibility as a result of their own material properties. Nanotechnology has the potential to overcome current chemotherapeutic barriers in cancer treatment, because of the unique nanoscale size and distinctive bioeffects of nanomaterials. Nanotechnology may help to solve the problems associated with traditional chemotherapy and multidrug resistance.
Strategies of engineering nanomedicines for tumor retention

Xindi Qian,Xiaoxuan Xu,Yao Wu,Jiaoying Wang,Jie Li,Shuo Chen,Jingyuan Wen,Yaping Li,Zhiwen Zhang

DOI: https://doi.org/10.1016/j.jconrel.2022.04.006

IF: 11.467

2022-06-01

Journal of Controlled Release

Abstract:The retention of therapeutic agents in solid tumors at sufficient concentration and duration is crucial for their antitumor effects. Given the important contribution of nanomedicines to oncology, we herein summarized two major strategies of nanomedicines for tumor retention, such as transformation- and interactions-mediated strategies. The transformation-mediated retention strategy was achieved by enlarging particle size of nanomedicines or modulating the morphology into fibrous structures, while the interactions-mediated retention strategy was accomplished by modulating nanomedicines to promote their interactions with versatile cells or components in tumors. Moreover, we provide some considerations and perspectives of tumor-retaining nanomedicines for effective cancer therapy.

pharmacology & pharmacy,chemistry, multidisciplinary
Nanomaterials in Cancer-Therapy Drug Delivery System

Gen Zhang,Xin Zeng,Ping Li

DOI: https://doi.org/10.1166/jbn.2013.1583

2013-01-01

Journal of Biomedical Nanotechnology

Abstract:Nanomaterials can enhance the delivery and treatment efficiency of anti-cancer drugs, and the mechanisms of the tumor-reducing activity of nanomaterials with cancer drug have been investigated. The task for drug to reach pathological areas has facilitated rapid advances in nanomedicine. Herein, we summarize promising findings with respect to cancer therapeutics based on nano-drug delivery vectors. Relatively high toxicity of uncoated nanoparticles restricts the use of these materials in humans. In order to reduce toxicity, many approaches have focused on the encapsulation of nanoparticles with biocompatible materials. Efficient delivery systems have been developed that utilized nanoparticles loaded with high dose of cancer drug in the presence of bilayer molecules. Well-established nanotechnologies have been designed for drug delivery with specific bonding. Surface-modified nanoparticles as vehicles for drug delivery system that contains multiple nano-components, each specially designed to achieve aimed task for the emerging application delivery of therapeutics. Drug-coated polymer nanoparticles could efficiently increase the intracellular accumulation of anti-cancer drugs. This review also introduces the nanomaterials with drug on the induction of apoptosis in cancer cells in vitro and in vivo. Direct interactions between the particles and cellular molecules to cause adverse biological responses are also discussed.

Engineering Nanoparticles to Tackle Tumor Barriers.

Engineering nanoparticles to tackle tumor barriers

Recent Advances in Nanostrategies Capable of Overcoming Biological Barriers for Tumor Management

Nano‐Engineering Strategies for Tumor‐Specific Therapy

Nano-engineering nanomedicines with customized functions for tumor treatment applications

New Nanomaterials and Techniques for Tumor-targeted Systems

Strategies to improve tumor penetration of nanomedicines through nanoparticle design

Recent Advances in Drug Delivery Systems for Enhancing Drug Penetration into Tumors

Barrier permeation and improved nanomedicine delivery in tumor microenvironments

The Design and Application of Nanomaterials as Drug Carriers in Cancer Treatment

Strategies for Delivering Nanoparticles across Tumor Blood Vessels

Bioengineering nanomaterials for tumor therapy and anti-metastasis

"Targeting Design" of Nanoparticles in Tumor Therapy

The progress and perspective of strategies to improve tumor penetration of nanomedicines

Overcoming tumor microenvironment obstacles: Current approaches for boosting nanodrug delivery

Engineering nanoparticles to reprogram radiotherapy and immunotherapy: recent advances and future challenges

Engineered nanoparticles for precise targeted drug delivery and enhanced therapeutic efficacy in cancer immunotherapy

Engineering Small Molecule Nanodrugs to Overcome Barriers for Cancer Therapy

Circumventing Tumor Resistance to Chemotherapy by Nanotechnology

Strategies of engineering nanomedicines for tumor retention

Nanomaterials in Cancer-Therapy Drug Delivery System